DCP EXCLUSIVELY INVESTS IN TURKEY AND IN TECHNOLOGY INTENSIVE PROJECTS AND START-UPS WHERE TIME TO MARKET IS REASONABLE FROM A COMMERCIALIZATION PERSPECTIVE.
We believe in the disruptive nature of science & technology driven innovation.
Once you are convinced that innovation and not just “business-model” innovation, but science and technology driven innovation is the engine for sustainable economic growth then you are left with no-choice but to admire and think of ways to support those entrepreneurs and scientists who challenge the status-quo to create social and commercial value.
At DCP we aim to find and invest in such teams that are building the future through progressive science and technology.
We think one of the main sources of innovation is at the junction of industry sectors. Therefore we focus on cross industry sectors and interdisciplinary projects to discover innovations occurring at the nexus of technology domains where capital efficient solutions can unlock significant value.
In addition to a competitive edge that stems from technology and intellectual property rights, we are looking for quantifiable market potential and the right entrepreneurial skill set for that market.
We constantly seek business models where such innovations are employed in a transformative fashion to disrupt existing markets.
To learn more please see our investment criteria.
At DCP we don’t just invest in visionary entrepreneurs and scientists but we strive to always think of ways to be enablers and supporters. We work hand in hand with our entrepreneurs to hit technical, financial and product deployment targets. With over 50 years of cumulative experience in the high-tech sectors, we provide our portfolio companies with business development, legal, IP, financial and operational knowhow.
We provide proof of concept, prototype and seed stage investments to IP intensive projects and university spinouts & startups. We scan Turkey for exciting technologies with a potential for fast transition from lab to market.
Our team has a proven track record of identifying viable market ready technologies and working with entrepreneurs to setup a streamlined business strategy to create sustainable high tech companies.
WE PRIMARILY CONDUCT PRE-SEED AND SEED INVESTMENTS. OUR INITIAL INVESTMENTS ARE TYPICALLY BELOW EUR500K. WE PREFER TO LEAD INVESTMENT ROUNDS BUT ALSO DO SYNDICATES WITH OTHER FUNDS AND ANGELS.
We are looking for entrepreneurial teams with global vision, focused, inquisitive, pragmatic and committed to the execution of the business plan.
The business plan built around the technology must be realistic and leverage technology’s competitive advantage.
We require our investments to have a strong technology component that is unique with a concrete intellectual property right (patents & copyrights) or trade secret component. The technology we invest in must have a clear, short to mid-term commercialization path from lab to market.
DCP has a generalist technology focus with an emphasis on bio-tech, green-tech, agri-tech, life sciences, materials & nanotechnology, IT, robotics and mechatronics. We will entertain submissions in other technology areas. However, we do not invest in e-commerce business models.
A biotech start-up developing microfluidics-based in-vitro diagnostic systems for rapid detection of Multiple Drug Resistance (MDR) and Circulating Tumor Cells (CTC).
Cybelle Laser is devising light based solutions for medical and aesthetics industries based on high precision image processing.
Api Heal is specialized in production technologies of natural functional-food and cosmetic ingredients.
Episome is a biotechnology company focusing on enzyme technologies in waste to energy sector. Episome aims to provide sustainable and environment friendly products for biogas, textile, leather, paper, starch, detergent, rubber and biofuel industries.